Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19)
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003225
- Lead Sponsor
- nion Hospital of Tongji Medical College, Huazhong University of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. novel coronavirus pneumonia diagnostic criteria;
2. age unlimited, male and female unlimited.
1. not qualified for novel coronavirus pneumonia diagnostic criteria;
2. Pregnant or lactating women who are allergic to the drug;
3. There are factors influencing the observation of curative effect;
4. Those who do not meet the inclusion criteria, fail to use the medicine according to the regulations, fail to determine the curative effect or incomplete data, which affect the judgment of curative effect or safety.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood biochemistry;chest CT;TCM symptom;C-reactive protein;Blood routine;2019-ncov-RNA;
- Secondary Outcome Measures
Name Time Method